Page last updated: 2024-10-21

2,2'-azobis(2-amidinopropane) and Colonic Neoplasms

2,2'-azobis(2-amidinopropane) has been researched along with Colonic Neoplasms in 3 studies

2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator

Colonic Neoplasms: Tumors or cancer of the COLON.

Research Excerpts

ExcerptRelevanceReference
"HT-29 colon cancer cells were exposed to heat (43 degrees C) in the presence of the ROS-generating drug, 2-2'-azobis-(2-amidinopropane) dihydrochloride (AAPH) for 1 h."1.34Thermal sensitization through ROS modulation: a strategy to improve the efficacy of hyperthermic intraperitoneal chemotherapy. ( Chen, F; Harrison, LE; Kim, E; Wang, CC, 2007)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peluso, I1
Romanelli, L1
Spagnuolo, S1
Manafikhi, H1
Palmery, M1
Halligan, EP1
Lowes, D1
Mistry, N1
Dove, R1
Cooke, M1
Evans, M1
Lunec, J1
Wang, CC1
Chen, F1
Kim, E1
Harrison, LE1

Other Studies

3 other studies available for 2,2'-azobis(2-amidinopropane) and Colonic Neoplasms

ArticleYear
Serum depletion, multidrug resistance and fluorescent probes: methodological implications in free radicals evaluation.
    Journal of immunological methods, 2014, Volume: 405

    Topics: Amidines; Animals; Biological Transport; Boron Compounds; Cell Line, Tumor; Cells, Cultured; Chick E

2014
A comparison of the gene expression profiles of CRL-1807 colonocytes exposed to endogenous AAPH-generated peroxides and exogenous peroxides from heated oil.
    Redox report : communications in free radical research, 2007, Volume: 12, Issue:1

    Topics: Amidines; Cell Cycle; Colon; Colonic Neoplasms; Diet; DNA Damage; DNA Repair; Gene Expression Profil

2007
Thermal sensitization through ROS modulation: a strategy to improve the efficacy of hyperthermic intraperitoneal chemotherapy.
    Surgery, 2007, Volume: 142, Issue:3

    Topics: Amidines; Caco-2 Cells; Cell Death; Cell Survival; Colonic Neoplasms; Combined Modality Therapy; Dos

2007